CN1277039A - Cancer treating medical composition - Google Patents
Cancer treating medical composition Download PDFInfo
- Publication number
- CN1277039A CN1277039A CN00110461A CN00110461A CN1277039A CN 1277039 A CN1277039 A CN 1277039A CN 00110461 A CN00110461 A CN 00110461A CN 00110461 A CN00110461 A CN 00110461A CN 1277039 A CN1277039 A CN 1277039A
- Authority
- CN
- China
- Prior art keywords
- radix
- pharmaceutical composition
- fructus
- composition according
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The medicine has a basic recipe comprising American ginseng, turtle shell, Rhizoma pinelliae, toad cake, musk, ground beetle, red sage and edible tulip, and is prepared through traditional process. It can regulate body's immunity, strengthen body's capability of eliminating macrophage and metabolism, kill cancer cell while protecting health cell, inhibit the metastasis and regeneration of tumor cell and promote restore after disease. It may be used to treat various tumors alone or during operation, radiotherapy and chemotherapy.
Description
The present invention relates to a kind of pharmaceutical composition for the treatment of cancer, is the Chinese patent medicine of feedstock production with the Chinese herbal medicine specifically, belongs to the Chinese medicine and pharmacy technical field.
At present, the Therapeutic Method such as operation, radiotherapy, chemotherapy that adopt when treatment malignant tumor disease more, above-mentioned Therapeutic Method all has its indication and contraindication, or has a very big toxic and side effects, do not reach effective therapeutic purposes, destroy the immunity labour function of human body easily, cause vital QI cannot conquer pathogen at last, make cancerous cell remaining in the body extensively breed transfer, invade the many places internal organs and cause patient death; Also there is not medicine that cancer is had curative effect preferably at present.
The object of the present invention is to provide a kind of pharmaceutical composition for the treatment of cancer, have good curative effect at multiple malignant tumor.
Solution of the present invention is based on pathogeny and the Therapeutic Principle of motherland's medical science to cancer, with reference to modern medical theory, based on strengthening vital QI to eliminate pathogenic factors, take inrigorating qi and promoting blood circulation, dispelling cold by warming the meridian, eliminating stasis and resolving masses and making laws, select the pure natural Chinese herbal medicine for use,, screen through strictness by the theory of Chinese medical science prescription, concoct respectively, combine in conjunction with modern advanced technologies method for making.
Basic recipe following (consumption is a ratio of weight and number):
Radix Panacis Quinquefolii 3～6, Carapax Trionycis 2～3.5, Rhizoma Pinelliae Preparatum 2～3.5, Venenum Bufonis 1～2,
Moschus 0.3～0.6, Eupolyphaga Seu Steleophaga 1～3, Radix Salviae Miltiorrhizae 1～3.5, Pseudobulbus Cremastrae seu Pleiones 3～5
Prepare optimization formula of the present invention following (weight portion):
Radix Panacis Quinquefolii 4～5.6, Carapax Trionycis 2.5～3.5, Rhizoma Pinelliae Preparatum 2.5～3, Venenum Bufonis 1.5～2,
Moschus 0.4～0.5, Eupolyphaga Seu Steleophaga 2～2.8, Radix Salviae Miltiorrhizae 2～3, Pseudobulbus Cremastrae seu Pleiones 3.5～4.5
At various dissimilar cancers, can on the basis of above-mentioned basic recipe, increase medicine and make compound prescription:
Compound recipe 1, be used for the treatment of the respiratory tract malignant tumor:
Radix Platycodonis 2～3, Radix Scrophulariae 2～3, Bulbus Fritillariae Cirrhosae 2～3, Radix Adenophorae (Radix Glehniae) 2～3,
Herba Portulacae Grandiflorae 2～3, Hedyotidis Diffusae 2～3, Fructus Trichosanthis 2～3, sea clam powder 2～3.
Compound recipe 2, be used for the treatment of breast tumor:
Bulbus Fritillariae Cirrhosae 2～3, Radix Platycodonis 2～3, roasted SQUAMA MANITIS into puffy with sand 1～2, Gekko Swinhonis 1～2,
Radix Bupleuri 1～2, Herba Scutellariae Barbatae 2～3, Hedyotidis Diffusae 2～3.
Compound recipe 3, be used for the treatment of gynecological tumor:
Oletum Trogopterori 1～2, Pollen Typhae 1～2, Radix Salviae Miltiorrhizae? 1～2, Rhizoma Curcumae 1～2,
Herba Pteridis Multifidae 2～3, Herba Scutellariae Barbatae 2～3, Hedyotidis Diffusae 2～3.
Compound recipe 4, be used for the treatment of primary hepatocarcinoma:
Semen Coicis 1～3.5, Rhizoma Curcumae 1～2, RHZOMA SPARGANII 1～2, Herba Scutellariae Barbatae 1～3.5,
Concha Arcae (calcined) 1～2.5, Radix Curcumae 1～2.5, Radix Bupleuri 1～2.5, Hedyotidis Diffusae 1～4.5.
Compound recipe 5, be used for the treatment of stomach and intestinal canal tumour:
Concha Erosariae seu Cypraeae 2～3, Concha Arcae (calcined) 2～3, Endothelium Corneum Gigeriae Galli 2～3, Rhizoma Curcumae 1～2,
Sal Ammoniacus 1～2, Haematitum 1～2, Endoconcha Sepiae 3～5.
Compound recipe 6, be used for the treatment of leukemia:
Indigo Naturalis 3～5, Realgar 1～2, Aloe 2～3, Fructus Camptothecae Acuminatae 2～3,
Hedyotidis Diffusae 2～5, Herba Scutellariae Barbatae 2～5, Cornu Bubali silk 2～5, artificial Calculus Bovis 1～2.
Compound recipe 7, be used for the treatment of malignant lymphoma:
Radix Ranunculi Ternati 1～3, Radix Codonopsis lanceolatae 1～3, Herba Catharanthi Rosei 1～3, sea clam powder 1～3,
Rhizoma Curcumae 1～3, Sargassum 1～3, Thallus Laminariae (Thallus Eckloniae) 1～3, Spica Prunellae 1～3.
Compound recipe 8: be used for the treatment of all kinds of middle and terminal cancers:
Radix Codonopsis 1～3.5, the Rhizoma Atractylodis Macrocephalae 1～2.5, Poria 1～2.5, the Radix Astragali 1～5.5,
Fructus Ligustri Lucidi 1～2.5, mend bone paper 1～2, Cornu Cervi Pantotrichum 1～1.5, Radix Angelicae Sinensis 1～2.5, Rhizoma Chuanxiong 1～2.5,
The Radix Paeoniae Alba 1～2.5, the Radix Rehmanniae 1～2.5, Radix Ophiopogonis 1～2.5, Fructus Schisandrae Chinensis 1～2, Arillus Longan 1～2.5,
JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 1～2, Rhizoma Polygonati Odorati 1～2, Pericarpium Citri Reticulatae 1～1.5, the Radix Aucklandiae 1～1.5, Fructus Amomi 1～2,
Fructus Corni 1～2.5, Caulis Spatholobi 1～2.5, the Cortex Eucommiae 1～2.5, Rhizoma Polygonati 1～2.5, Radix Polygoni Multiflori 1～2
Preparation technology of the present invention is:
Above-mentioned prescription is taken by weighing by each component ratio, and strict the process of preparing Chinese medicine with the traditional handicraft method processed.Last all medicines are except that Moschus, and clean dry is ground into fine powder, mix homogeneously behind mistake 120 mesh sieves, and reuse equivalent incremental method and Moschus powder grind well, and become loose powder after sieve series, and kept dry is stand-by;
For compound recipe 8, also can be made into oral liquid, be convenient to take.Except that Moschus, said medicine was decocted 2 hours, decocted 1.5 hours for the second time, decocted for the third time 1 hour, supernatant is all got in three decoctions, and mix homogeneously filters decontamination, the medicinal liquid of reconcentration to 1 milliliter, when quite crude drug in whole 2 restrains, the cooling back adds 95% ethanol of medicinal liquid doubling dose, stirs, and leaves standstill 24 hours after-filtration, filtrate decompression is concentrated into the extractum shape, with an amount of water dilution, cold preservation was filtered in 24 hours, added simple syrup, sodium benzoate, Moschus, add entry again and make oral liquid, cold preservation, filter, be packaged in 10 milliliters of peace bottles, 100 degree high temperature sterilizes 30 minutes get this product.
Instructions about how to take medicine consumption: at every turn take 10 milliliters, every day 2～3 times.
Be monarch with the Radix Panacis Quinquefolii among the present invention, QI invigorating is set upright, and improves immune function of human body, Carapax Trionycis, Rhizoma Pinelliae Preparatum, Pseudobulbus Cremastrae seu Pleiones softening and eliminating sputum eliminating stagnation are ministerial drug, help again with Radix Salviae Miltiorrhizae, Eupolyphaga Seu Steleophaga blood circulation promoting and blood stasis dispelling, the detoxifcation of having one's ideas straightened out of Venenum Bufonis, Moschus, all medicines complement each other, and to reach QI and blood jointly vigorous, blood circulation depending on qi flow, remove the disease of YIN-cold internal resistance in the human body, tumor can be softened, dwindle, disappear, reach the healing purpose.
Compound recipe 1 supplementing QI and nourishing YIN, dissipating phlegm and resolving masses.Be used for the treatment of respiratory tract neoplasms.
Compound recipe 2 depressed liver-energy dispersing and QI regulating, hard masses softening and resolving.Be used for each phase treatment of breast tumor.
Compound recipe 3 blood circulation promoting and blood stasis dispelling, hard masses softening and resolving.Cure mainly gynecological tumors such as uterus carcinoma, ovarian cancer.
Compound recipe 4 dispersing the stagnated live-QI to relieve the stagnation of QI, movable blood soft hard.The treatment primary hepatocarcinoma.
Compound recipe 5 normalizing the stomach by guiding QI downward, removing food stagnancyization stagnate.Treatment stomach and intestinal canal tumour.
Compound recipe 6 nourishing the liver and kidney, removing pathogenic heat from blood and toxic substance from the body.Various leukemia are treated.
Compound recipe 7 blood circulation promoting and blood stasis dispelling, resolving phlegm and softening hard masses.The treatment lymph tumor.
Compound recipe 8 right supporting anticancers, invigorating the spleen and benefiting QI.Right supporting anticancer, invigorating the spleen and benefiting QI consolidates, and is mainly used in the middle and terminal cancer patient, and body is extremely weak, can not take care of oneself, inappetence, or because of operation, the caused various toxicities of chemicotherapy.Improve patient's life quality, reduce the patients clinical misery, prolong patient's life cycle.
This pharmaceutical composition is the lark powder.
Instructions of taking: each 3～5 grams of being grown up, every day 2 times, eliminating cold for resuscitation water clothes down.
Characteristics of the present invention are to select the pure natural medical prescription fully for use; traditional handicraft is concocted; has the immunologic function of regulating human body; strengthen the phagocytic activity and the metabolic activity of the macrophage of human body; kill and wound cancerous cell and protect the normal health body cell; suppress the transfer and the regeneration of tumor cell, promote rehabilitation function after being ill.
The clinical treatment that is used for various different tumors, each phase tumor also can use simultaneously in conjunction with operation, radiotherapy, chemotherapy, can make state of an illness long-term remission, and the effect that does not shift, do not recur is arranged.
According to the TNM classification of International Union Against Cancer (UICC) and the sort merge of american cancer community (ALCC), the TNM that works out by stages, case is selected the 1st phase and the 2nd phase tumor patient and the 3rd phase of minority patient by clinical manifestation, with the 1st phase is that main body is taken medicine of the present invention respectively and common drug carries out the clinical contrast observation.Matched group selects for use alkylating agent, anti-metabolism, antibiotics and plant class for chemotherapeutics commonly used according to the state of an illness, treats with conventional medication.Two groups except that Drug therapy, all select for use non-pharmaceutical method to carry out auxiliary treatment, as: quit smoking, the absorption of wine, food such as pungent, fried; Blood pressure person on the low side should give easily to digest nourishing food and strengthen nutrition; Attention is struck a proper balance between work and rest, and suitably has sports, and improves the immunologic function of self.
Test group is arranged 100 examples, wherein, and 40～50 years old 18 example, 51～60 years old 35 example, 49 examples more than 60 years old, male 54 examples, women 48 examples; The 1st phase tumor 5 examples, the 2nd phase tumor 68 examples, the 3rd phase tumor 29 examples.
Matched group is arranged 94 examples, 40～50 years old 14 example wherein, 51～60 years old 32 example, 60 years old last 48 example, male 50 examples, women 44 examples; The 1st phase tumor 4 examples, the 2nd phase tumor 56 examples, the 3rd phase tumor 34 examples.
Treatment time and inspection item: the 1st phase tumor patient course of treatment of taking medicine is one month, takes medicine a course of treatment.2nd, 3 phase tumor patients are a course of treatment to take medicine 3 months all.The 2nd phase tumor patient is taken medicine two courses of treatment; The 3rd phase tumor patient is taken medicine 3 courses of treatment.Carry out X line or hemogram checking per 2 weeks of the 2nd phase tumor patient once, the 3rd phase tumor patient carried out X line, the hemogram checking except that per 2 weeks, also should add the situation of Liver and kidney is checked, after finishing the course of treatment, checked the whole emergencing testeding projects of tumor.
1, alleviate (CR) fully: X line, fiberscopy focus all absorb, clinical no various malaise symptoms, the normal person of every index inspection.
2, produce effects: tumor focus disappears substantially after taking medicine, and every inspection index is tending towards normally, and after two weeks of drug withdrawal, clinical various symptoms and sign are still kept normal person.
3, effective and invalid: the back remission rate of taking medicine, in the X-ray film, it is effective that the tumor maximum gauge multiply by its perpendicular diameter than dwindling before treating more than 50%, is invalid below 50%.
Be listed as follows by observed result: test group test group and matched group:
| Clinical tumor by stages | Case load | Alleviate fully | Produce effects | Effectively | Invalid | ||||
| Case load | Account for current period % | Case load | Account for current period % | Case load | Account for current period % | Case load | Account for current period % | ||
| The 1st phase | 5 | ?5 | ?100 | ||||||
| The 2nd phase | 68 | ?45 | ?66.2 | ?14 | ?20.6 | ?8 | ?11.8 | ?1 | ?2 |
| The 3rd phase | 29 | ?15 | ?51.7 | ?10 | ?34.5 | ?3 | ?10.3 | ?1 | ?3.5 |
| Add up to | 102 | ?65 | ?63.7 | ?24 | ?23.5 | ?11 | ?10.8 | ?2 | ?2 |
Matched group:
| Clinical tumor by stages | Case load | Alleviate fully | Produce effects | Effectively | Invalid | ||||
| Case load | Account for current period % | Case load | Account for current period % | Case load | Account for current period % | Case load | Account for current period % | ||
| The 1st phase | 5 | ?4 | ?80 | ?1 | ?20 | ||||
| The 2nd phase | 57 | ?25 | ?43.9 | ?21 | ?36.8 | ?10 | ?17.5 | ?1 | ?1.8 |
| The 3rd phase | 32 | ?5 | ?15.6 | ?18 | ?56.3 | ?6 | ?18.8 | ?3 | ?9.3 |
| Add up to | 94 | ?34 | ?36.1 | ?40 | ?42.6 | ?16 | ?17 | ?4 | ?4.3 |
Test group and matched group tumor situation of change as can be seen from the above table, test group is alleviated fully and total effective rate all is higher than matched group, and the inefficiency test group is lower 2～3 percentage points than matched group.This invention is obvious to the remission effect of tumor, and is stable lasting, and without any side effects, do not rebound treating both the principal and secondary aspects of a disease.
Embodiment 1
Take by weighing medicine by following proportioning: Radix Panacis Quinquefolii 5.6kg, Carapax Trionycis 3.5kg, Rhizoma Pinelliae Preparatum 3kg, Venenum Bufonis 2kg, Moschus 0.5kg, Eupolyphaga Seu Steleophaga 2.8kg, Radix Salviae Miltiorrhizae 3kg, Pseudobulbus Cremastrae seu Pleiones 4.5kg, go up all medicines except that Moschus, clean dry is ground into fine powder, cross mix homogeneously behind 120 mesh sieves, reuse equivalent incremental method and Moschus powder grind well, become loose powder after sieve series, kept dry essential drugs to be used as;
Embodiment 2
The medicine that is used for the treatment of the respiratory tract malignant tumor, take by weighing medicine by embodiment 1 same proportioning, other takes by weighing: Radix Platycodonis 3kg, Radix Scrophulariae 3kg, Bulbus Fritillariae Cirrhosae 3kg, Radix Adenophorae (Radix Glehniae) 3kg, Herba Portulacae Grandiflorae 3kg, Hedyotidis Diffusae 3kg, Fructus Trichosanthis 3kg, sea clam powder 3kg, go up all medicines except that Moschus, clean dry is ground into fine powder, cross mix homogeneously behind 120 mesh sieves, reuse equivalent incremental method and Moschus powder grind well, and become loose powder after sieve series.
Embodiment 3
Be used for the treatment of breast tumor: take by weighing medicine by embodiment 1 same proportioning, take by weighing Bulbus Fritillariae Cirrhosae kg3, Radix Platycodonis 3kg, roasted SQUAMA MANITIS into puffy with sand 2kg, Gekko Swinhonis 2kg, Radix Bupleuri 2kg, Herba Scutellariae Barbatae 3kg, Hedyotidis Diffusae 3kg in addition again, go up all medicines except that Moschus, clean dry is ground into fine powder, cross mix homogeneously behind 120 mesh sieves, reuse equivalent incremental method and Moschus powder grind well, and become loose powder after sieve series.
Embodiment 4
Be used for the treatment of gynecological tumor: take by weighing the same medicine of embodiment 1, other gets Oletum Trogopterori 2kg, Pollen Typhae 2kg, Radix Salviae Miltiorrhizae 2kg, Rhizoma Curcumae 2kg, Herba Pteridis Multifidae 3kg, Herba Scutellariae Barbatae 3kg, Hedyotidis Diffusae 3kg, go up all medicines except that Moschus, clean dry is ground into fine powder, cross mix homogeneously behind 120 mesh sieves, reuse equivalent incremental method and Moschus powder grind well, and become loose powder after sieve series.
Embodiment 5
Be used for the treatment of primary hepatocarcinoma: take by weighing the same medicine of embodiment 1, other gets Semen Coicis 3.5kg, Rhizoma Curcumae 2kg, RHZOMA SPARGANII 2kg, Herba Scutellariae Barbatae 3.5kg, Concha Arcae (calcined) 2.5kg, Radix Curcumae 2.5kg, Radix Bupleuri 2.5kg, Hedyotidis Diffusae 4.5kg, go up all medicines except that Moschus, clean dry is ground into fine powder, cross mix homogeneously behind 120 mesh sieves, reuse equivalent incremental method and Moschus powder grind well, and become loose powder after sieve series.
Embodiment 6
Be used for the treatment of stomach and intestinal canal tumour: take by weighing the same medicine of embodiment 1, other gets Concha Erosariae seu Cypraeae 3kg, Concha Arcae (calcined) 3kg, Endothelium Corneum Gigeriae Galli 3kg, Rhizoma Curcumae 2kg, Sal Ammoniacus 2kg, Haematitum 2kg, Endoconcha Sepiae 5kg, go up all medicines except that Moschus, clean dry is ground into fine powder, cross mix homogeneously behind 120 mesh sieves, reuse equivalent incremental method and Moschus powder grind well, and become loose powder after sieve series.
Embodiment 7
Be used for the treatment of leukemia: take by weighing the same medicine of embodiment 1; other gets Indigo Naturalis 5kg, Realgar 2kg, Aloe 3kg, Fructus Camptothecae Acuminatae 3kg, Hedyotidis Diffusae 5kg, Herba Scutellariae Barbatae 5kg, Cornu Bubali silk 5kg, artificial Calculus Bovis 2kg; go up all medicines except that Moschus; clean dry is ground into fine powder; cross mix homogeneously behind 120 mesh sieves; reuse equivalent incremental method and Moschus powder grind well, and become loose powder after sieve series.
Embodiment 8
Be used for the treatment of malignant lymphoma: take by weighing the same medicine of embodiment 1, other gets Radix Ranunculi Ternati 3kg, Radix Codonopsis lanceolatae 3kg, Herba Catharanthi Rosei 3kg, sea clam powder 3kg, Rhizoma Curcumae 3kg, Sargassum 3kg, Thallus Laminariae (Thallus Eckloniae) 3kg, Spica Prunellae 3kg, go up all medicines except that Moschus, clean dry is ground into fine powder, cross mix homogeneously behind 120 mesh sieves, reuse equivalent incremental method and Moschus powder grind well, and become loose powder after sieve series.
Embodiment 9
Be used for the treatment of all kinds of middle and terminal cancers: take by weighing the same medicine of embodiment 1, other gets Radix Codonopsis 3.5kg, Rhizoma Atractylodis Macrocephalae 2.5kg, Poria 2.5kg, Radix Astragali 5.5kg, Fructus Ligustri Lucidi 2.5kg, mend bone paper 2kg, Cornu Cervi Pantotrichum 1.5kg, Radix Angelicae Sinensis 2.5kg, Rhizoma Chuanxiong 2.5kg, Radix Paeoniae Alba 2.5kg, Radix Rehmanniae 2.5kg, Radix Ophiopogonis 2.5kg, Fructus Schisandrae Chinensis 2kg, Arillus Longan 2.5kg, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 2kg, Rhizoma Polygonati Odorati 2kg, Pericarpium Citri Reticulatae 1.5kg, Radix Aucklandiae 1.5kg, Fructus Amomi 2kg, Fructus Corni 2.5kg, Caulis Spatholobi 2.5kg, Cortex Eucommiae 2.5kg, Rhizoma Polygonati 2.5kg, Radix Polygoni Multiflori kg2, except that Moschus, said medicine was decocted 2 hours, decocted 1.5 hours for the second time, decocted for the third time 1 hour, decoct for three times and all get supernatant, and mix homogeneously filters decontamination, the medicinal liquid of reconcentration to 1 milliliter, when quite crude drug in whole 2 restrains, the cooling back adds 95% ethanol of medicinal liquid doubling dose, stir, leave standstill 24 hours after-filtration, filtrate decompression is concentrated into the extractum shape, with an amount of water dilution, cold preservation was filtered in 24 hours, add simple syrup, sodium benzoate, Moschus, add entry again and make oral liquid, cold preservation, filter, be packaged in 10 milliliters of peace bottles, 100 degree high temperature sterilizes 30 minutes get this product.
Claims (11)
1, a kind of pharmaceutical composition for the treatment of cancer is characterized in that the basic recipe of being made up of following natural drug: (for ratio of weight and number):
Radix Panacis Quinquefolii 3～6, Carapax Trionycis 2～3.5, Rhizoma Pinelliae Preparatum 2～3.5, Venenum Bufonis 1～2,
Moschus 0.3～0.6, Eupolyphaga Seu Steleophaga 1～3, Radix Salviae Miltiorrhizae 1～3.5, Pseudobulbus Cremastrae seu Pleiones 3～5.
2, pharmaceutical composition according to claim 1 is characterized in that: optimization formula following (weight portion):
Radix Panacis Quinquefolii 4～5.6, Carapax Trionycis 2.5～3.5, Rhizoma Pinelliae Preparatum 2.5～3, Venenum Bufonis 1.5～2,
Moschus 0.4～0.5, Eupolyphaga Seu Steleophaga 2～2.8, Radix Salviae Miltiorrhizae 2～3, Pseudobulbus Cremastrae seu Pleiones 3.5～4.5.
3, pharmaceutical composition according to claim 1 is characterized in that also having:
Radix Platycodonis 2～3, Radix Scrophulariae 2～3, Bulbus Fritillariae Cirrhosae 2～3, Radix Adenophorae (Radix Glehniae) 2～3,
Herba Portulacae Grandiflorae 2～3, Hedyotidis Diffusae 2～3, Fructus Trichosanthis 2～3, sea clam powder 2～3.
4, pharmaceutical composition according to claim 1 is characterized in that also having:
Bulbus Fritillariae Cirrhosae 2～3, Radix Platycodonis 2～3, roasted SQUAMA MANITIS into puffy with sand 1～2, Gekko Swinhonis 1～2,
Radix Bupleuri 1～2, Herba Scutellariae Barbatae 2～3, Hedyotidis Diffusae 2～3.
5, pharmaceutical composition according to claim 1 is characterized in that also having:
Oletum Trogopterori 1～2, Pollen Typhae 1～2, Radix Salviae Miltiorrhizae 1～2, Rhizoma Curcumae 1～2,
Herba Pteridis Multifidae 2～3, Herba Scutellariae Barbatae 2～3, Hedyotidis Diffusae 2～3.
6, pharmaceutical composition according to claim 1 is characterized in that also having:
Semen Coicis 1～3.5, Rhizoma Curcumae 1～2, RHZOMA SPARGANII 1～2, Herba Scutellariae Barbatae 1～3.5,
Concha Arcae (calcined) 1～2.5, Radix Curcumae 1～2.5, Radix Bupleuri 1～2.5, Hedyotidis Diffusae 1～4.5.
7, pharmaceutical composition according to claim 1 is characterized in that also having:
Concha Erosariae seu Cypraeae 2～3, Concha Arcae (calcined) 2～3, Endothelium Corneum Gigeriae Galli 2～3, Rhizoma Curcumae 1～2,
Sal Ammoniacus 1～2, Haematitum 1～2, Endoconcha Sepiae 3～5.
8, pharmaceutical composition according to claim 1 is characterized in that also having:
Indigo Naturalis 3～5, Realgar 1～2, Aloe 2～3, Fructus Camptothecae Acuminatae 2～3,
Hedyotidis Diffusae 2～5, Herba Scutellariae Barbatae 2～5, Cornu Bubali silk 2～5, artificial Calculus Bovis 1～2.
9, pharmaceutical composition according to claim 1 is characterized in that also having:
Radix Ranunculi Ternati 1～3, Radix Codonopsis lanceolatae 1～3, Herba Catharanthi Rosei 1～3, sea clam powder 1～3,
Rhizoma Curcumae 1～3, Sargassum 1～3, Thallus Laminariae (Thallus Eckloniae) 1～3, Spica Prunellae 1～3.
10, pharmaceutical composition according to claim 1 is characterized in that also having:
Radix Codonopsis 1～3.5, the Rhizoma Atractylodis Macrocephalae 1～2.5, Poria 1～2.5, the Radix Astragali 1～5.5,
Fructus Ligustri Lucidi 1～2.5, mend bone paper 1～2, Cornu Cervi Pantotrichum 1～1.5, Radix Angelicae Sinensis 1～2.5, Rhizoma Chuanxiong 1～2.5,
The Radix Paeoniae Alba 1～2.5, the Radix Rehmanniae 1～2.5, Radix Ophiopogonis 1～2.5, Fructus Schisandrae Chinensis 1～2, Arillus Longan 1～2.5,
JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 1～2, Rhizoma Polygonati Odorati 1～2, Pericarpium Citri Reticulatae 1～1.5, the Radix Aucklandiae 1～1.5, Fructus Amomi 1～2,
Fructus Corni 1～2.5, Caulis Spatholobi 1～2.5, the Cortex Eucommiae 1～2.5, Rhizoma Polygonati 1～2.5, Radix Polygoni Multiflori 1～2.
11, according to the described pharmaceutical composition of claim 1 to 10, it is characterized in that: comprise any pharmaceutical dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001104616A CN1183919C (en) | 2000-05-26 | 2000-05-26 | Cancer treating medical composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001104616A CN1183919C (en) | 2000-05-26 | 2000-05-26 | Cancer treating medical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1277039A true CN1277039A (en) | 2000-12-20 |
| CN1183919C CN1183919C (en) | 2005-01-12 |
Family
ID=4580450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001104616A Expired - Fee Related CN1183919C (en) | 2000-05-26 | 2000-05-26 | Cancer treating medical composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1183919C (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003086426A1 (en) * | 2002-04-17 | 2003-10-23 | Yongzhong Li | A set of chinese medicine for preventing and treating cancer |
| CN102058744A (en) * | 2010-11-25 | 2011-05-18 | 代龙 | Chinese medicinal composition for treating malignant tumor and preparation method thereof |
| CN102600279A (en) * | 2012-03-31 | 2012-07-25 | 孟凡久 | Traditional Chinese medicine for treating cancer |
| CN103272054A (en) * | 2013-06-14 | 2013-09-04 | 袁军清 | Traditional Chinese medicine for treating leukemia |
| CN103386084A (en) * | 2013-07-19 | 2013-11-13 | 苏州市天灵中药饮片有限公司 | Decoction for treating liver cirrhosis |
| CN105288374A (en) * | 2014-07-08 | 2016-02-03 | 张明学 | Traditional Chinese medicine composition for treating cancer and method for preparing traditional Chinese medicine composition |
| CN105687664A (en) * | 2016-03-04 | 2016-06-22 | 上海交通大学医学院附属第九人民医院 | Traditional Chinese medicine condensed pill for treating head and neck neoplasms and preparation method thereof |
| CN106075141A (en) * | 2016-07-26 | 2016-11-09 | 贵州医科大学 | A kind of anti-tumor Chinese medicine and preparation method thereof |
| CN106075182A (en) * | 2016-06-25 | 2016-11-09 | 聂超 | A kind of anticancer Traditional chinese medicine medicament formula |
| CN106266605A (en) * | 2016-10-26 | 2017-01-04 | 商洛学院 | A kind of composition of medicine for treating hepatocarcinoma and using method thereof |
| CN108273003A (en) * | 2018-03-02 | 2018-07-13 | 成都知联汇科技有限公司 | A kind of anti-cancer agent series and its production method |
| CN109248286A (en) * | 2018-11-27 | 2019-01-22 | 李天基 | A kind of drug and preparation method thereof for treating lymph cancer |
-
2000
- 2000-05-26 CN CNB001104616A patent/CN1183919C/en not_active Expired - Fee Related
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003086426A1 (en) * | 2002-04-17 | 2003-10-23 | Yongzhong Li | A set of chinese medicine for preventing and treating cancer |
| CN102058744A (en) * | 2010-11-25 | 2011-05-18 | 代龙 | Chinese medicinal composition for treating malignant tumor and preparation method thereof |
| CN102600279A (en) * | 2012-03-31 | 2012-07-25 | 孟凡久 | Traditional Chinese medicine for treating cancer |
| CN103272054A (en) * | 2013-06-14 | 2013-09-04 | 袁军清 | Traditional Chinese medicine for treating leukemia |
| CN103272054B (en) * | 2013-06-14 | 2015-05-13 | 袁军清 | Traditional Chinese medicine for treating leukemia |
| CN103386084A (en) * | 2013-07-19 | 2013-11-13 | 苏州市天灵中药饮片有限公司 | Decoction for treating liver cirrhosis |
| CN105288374A (en) * | 2014-07-08 | 2016-02-03 | 张明学 | Traditional Chinese medicine composition for treating cancer and method for preparing traditional Chinese medicine composition |
| CN105687664A (en) * | 2016-03-04 | 2016-06-22 | 上海交通大学医学院附属第九人民医院 | Traditional Chinese medicine condensed pill for treating head and neck neoplasms and preparation method thereof |
| CN106075182A (en) * | 2016-06-25 | 2016-11-09 | 聂超 | A kind of anticancer Traditional chinese medicine medicament formula |
| CN106075141A (en) * | 2016-07-26 | 2016-11-09 | 贵州医科大学 | A kind of anti-tumor Chinese medicine and preparation method thereof |
| CN106266605A (en) * | 2016-10-26 | 2017-01-04 | 商洛学院 | A kind of composition of medicine for treating hepatocarcinoma and using method thereof |
| CN108273003A (en) * | 2018-03-02 | 2018-07-13 | 成都知联汇科技有限公司 | A kind of anti-cancer agent series and its production method |
| CN109248286A (en) * | 2018-11-27 | 2019-01-22 | 李天基 | A kind of drug and preparation method thereof for treating lymph cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1183919C (en) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1060664C (en) | Chinese drug for curing and preventing mastosis and its preparing method | |
| CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
| CN1095610A (en) | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases | |
| CN1183919C (en) | Cancer treating medical composition | |
| CN100528211C (en) | Traditional Chinese medicine for treating tumor | |
| CN102961636B (en) | Pure traditional Chinese medicine composition for treating poultry infectious bursal disease and preparation method thereof | |
| CN1486740A (en) | Chinese medicine composition for treating cancer | |
| CN1814208A (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN1167452C (en) | Medicine for treating AIDS | |
| CN102670770B (en) | Compound propolis pure Chinese medicinal composition for treating white scour of piglets and preparation method thereof | |
| CN1232298C (en) | Medication for treating malignant tumor and preparation method | |
| CN1049827C (en) | Anti-cancer powder | |
| CN101406594B (en) | Chinese medicine for treating tumor of lung | |
| CN1218721C (en) | Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease | |
| CN1188153C (en) | Medicines for treating cancers and tumours | |
| CN102600325B (en) | Compound propolis composition for treatment of porcine contagious pleuropneumonia and preparation method thereof | |
| CN102397528B (en) | Compound propolis composition for treating chicken infectious anemia and preparation method thereof | |
| CN107854565B (en) | Anti-radiation traditional Chinese medicine composition | |
| CN1171601C (en) | Medicine 'Shenfeishu' for treating nephrosis and lung disease and its preparing process | |
| CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
| CN105213511A (en) | A kind of pharmaceutical composition is for the preparation of the purposes in treatment amenorrhea medicine | |
| CN1187064C (en) | Medicine for treating epidemic hemorrhagic fever | |
| CN1159054C (en) | Tongfuzhixie preparation | |
| CN1130529A (en) | Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof | |
| CN102397529B (en) | Compound propolis composition for treating chicken reticuloendotheliosis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050112 Termination date: 20100526 |